INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Vantage Consulting Group Inc's Holding History (CIK: 0001843547)

Note: Option positions (PUT/CALL) are excluded.

Q4 2021
Shares 226,670 Value ($000) $11,864 Avg Close — Range —
Q3 2021
Shares 226,670 Value ($000) $8,450 Avg Close — Range —
Q2 2021
Shares 226,670 Value ($000) $9,252 Avg Close — Range —
Q1 2021
Shares 226,670 Value ($000) $7,690 Avg Close — Range —
Q4 2020
Shares 226,670 Value ($000) $7,208 Avg Close — Range —